There is clear evidence to prove that vaccination programs save approximately three million lives every year, around the world. Previously devastating diseases such as smallpox have been eradicated and incidences of others, such as polio, measles and diphtheria, are dramatically declining. Yet, vaccines are perhaps the most divisive recent development in the medical sciences. This is because, along with these substantial benefits, vaccines have also brought with them a number of challenges, including the suspicion of vaccines as a new health technology, issues of intellectual property rights, mechanisms of funding vaccine development, and concerns about ensuring that they are used by those who need them most, in the poorest parts of the world.
Baird’s CMC has immense experience in engaging with issues such as these. We have undertaken a range of projects that attempt to overcome one or more of these challenges by employing our long-standing expertise in strategic communications, issue-led advocacy campaigns, and in-depth market and policy research. To get an idea of Baird’s CMC’s experience in this area, please see our case studies.
Baird’s CMC experts: Mark Chataway, Aman Gupta, James Snodgrass, Francois Baird
1Prevention is better than cure, ABPI
2Vaccinate your baby